Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Georg Gerber
Brigham and Women's Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Kaleido Biosciences, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research proposes to develop a suite of software tools for analyzing microbiome dynamics. The company is developing novel chemistries to systematically influence the resident microbiome to treat disease and improve human health. One of the data sets used to perform secondary analyses of the algorithms is the company’s data set.
Bayesian Machine Learning Tools for Analyzing Microbiome Dynamics
The human microbiota, or collection of micro-organisms living on and within us, plays an important role in health, and when disrupted or abnormal, may contribute to many types of diseases including infections, kidney diseases, bowel diseases, diabetes, heart diseases, arthritis, allergies, brain diseases, and cancer. Sophisticated computer-based tools are needed to make sense of human microbiota data, particularly time- series data, which can yield important insights into how our microbiomes change over time. This work will develop new and improved computer-based tools for analyzing microbiota time-series data, which will be made freely available and will enable scientists to increase our fundamental knowledge about how our microbiota affect us and ultimately to apply this knowledge to prevent and treat human illnesses.
Filed on October 24, 2018.
Tell us what you know about Georg Gerber's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Georg Gerber”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Georg Gerber | Boston Children's Hospital | Conflict of Interest | Consortia Therapeutics | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.